-transparent.png){kind=logo}
The effect of bezafibrate (3 x 200 mg/day) on biliary lipids was studied in 12 healthy male subjects and in 13 patients with hyperlipidemias. In normal subjects, the lithogenic index, with bezafibrate and placebo administered in a double blind cross-over design, was 1.1 and 0.77 respectively. The difference was not significant. In patients, who have been treated with bezafibrate for 6 months to 3 years the index was 0.76, and 0.64 six weeks after discontinuation of the drug. This difference, too, was not significant. It appears, therefore, that contrary to findings with clofibrate, bezafibrate may not be associated with an increased risk of cholelithiasis. This question, however, can ultimately be answered with certainty only on the basis of long-time epidemiologic evidence.
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
October 1981,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
October 1975,
Revista medica de Chile,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
January 1982,
Klinische Wochenschrift,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
August 1975,
MMW, Munchener medizinische Wochenschrift,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
December 1972,
Revista espanola de fisiologia,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
October 1986,
Orvosi hetilap,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
January 1978,
Seikagaku. The Journal of Japanese Biochemical Society,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
January 1995,
European journal of drug metabolism and pharmacokinetics,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
April 1986,
Atherosclerosis,
G Schlierf, and
H Fischer, and
A Roche, and
A Stiehl, and
P Oster, and
B Schellenberg, and
J Vollmar
April 1979,
Wiener klinische Wochenschrift,
